12:12 PM EST - Pharmala Biotech Holdings Inc : Announced that it has signed an agreement with SABI Mind Inc. which will allow for its GMP MDMA to be administered to patients at SABI Mind's Healing Centres. SABI Mind is a leading and rapidly growing psychedelic clinic and research organization that provides psychedelic-assisted therapies in Calgary and at upcoming locations in Edmonton and Victoria. Pharmala Biotech Holdings Inc
shares C.MDMA are trading unchanged at $0.03.
